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Background: Integrons, which are short sequences of DNA like
ransposons have the capability of transferring genes of antibiotic
esistance to other bacteria .Studies have revealed that these ele-
ents could bear the Extended Spectrum Beta Lactamase, (ESBL),
enes that are transmitted to many strains of bacteria especially
nterobacteriaceae members. The aim of this study was to deter-
ine prevalence of integron elements and gene groups encoding
SBLs in E.coli and Klebsiella pneumoniae isolated from urine spec-
mens.
Methods: In total 5000 specimen were collected from children
ith UTI referred to Moﬁd children hospital in Tehran, during
he 6 month study period by consecutive sampling. The 100 con-
rmed isolates ofE.coli and50Klebsiella pneumoniaewere tested for
usceptibility to different antimicrobial drugs like cefotaxime, cef-
riaxone, cefpodoxime, aztreonam, ceftazidime, cefpodoxime plus
lavulanate Antibiotic susceptibility testing was performed by disk
iffusion method and E-test method were used for detection MIC.
SBL positive bacteria were preserved in -70 ◦C freezers and ﬁnally
CR performed on them.
Results: The gene groups studied for presences of ESBL were
TX, TEM, SHV and Int.Thirty isolates of E.coli were positive for
SBL; the frequency of gene groups was as follows: CTX (24), TEM
26), SHV (15), and Int (12). In the 19 isolated stains of Klebsiella
neumonia positive for ESBL the frequency of gene groupswas: CTX
18), TEM (18), SHV (15) and Int (10). The prevalence of class 1 Inte-
rons was 52% in non-outbreak E. coli isolates and 48% in Klebsiella
neumoniae isolates from patients in our study. Less than half of
he selected isolates from patients’ samples that we tested were
ositive for class 1 Integron. 48% of Klebsiella pneumoniae and 54%
f E.coli strains possessed Integron and ESBL genes concomitantly.
Conclusion: our study showed a high rate of ESBLS among of
.coli and K.peumoniae isolates. In our study imipenem following
mikacin were the most effective antibiotic against ESBLs isolates.
owever emerging resistance to these antibiotics in future may
imit their prescription.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.587fectious Diseases 16S (2012) e317–e473 e423
Type: Poster Presentation
Final Abstract Number: 56.037
Session: Antibiotics
Date: Saturday, June 16, 2012
Time: 12:45-14:15
Room: Poster & Exhibition Area
Prevalence of extended spectrum -lactamases (ESBLs), AmpC,
Carbapenemases and New Delhi metallo-beta-lactamase (NDM)
among 869 blood stream (BS) isolates of Enterobacteriaceae
obtained from ﬁve Indian Hospitals during 2007 – 2010
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Background: Clinicians rationalize their empirical antimicro-
bial choice in order to ensure better patient outcome and with
minimal emergence of resistance (R) benchmarked on local or
national data. Our group had reported high ESBL prevalence (>75%)
occurring among 2782 Enterobacteriaceae strains collected from
ﬁve national hospitals during 2007 to 2010. We report R-rates to
other antimicrobial classes among 869 BS isolates.
Methods: Minimum Inhibitory Concentrations (MIC) were
determined by Etest to commonly used ﬁve classes: pipera-
cilin/tazobactam (P/T); levoﬂoxacin (LEV); amikacin (AK); car-
bapenems (CARB) and tigecycline (TIG).ESBLs were screened and
conﬁrmed by cefotaxime+ clavulanic acid (CL) and ceftazidime +
CL Etest strips. Combined Disk diffusion test (CDDT) for screen-
ing Amp C, and metallobetalactamases (MBL) was done. R to any
one: imipenem (IMP), meropenem (MEM) or ertapenem (ETP) was
deﬁnedasCARB-Rand further screened for carbapenemaseproduc-
tion by Modiﬁed Hodge Test. PCR was done to detect ESBL, AmpC
and MBL presence. Infection was clinically deﬁned as CA when
acquired as outpatient with no reports of hospitalization up to 1
year andpatients didnothaveany features of health care associated
infections. A 14 -day mortality outcome was assessed.
Results:Overall ESBL ratewas82.6%. R rates (%)were: LEV (70.6)
>P/T (40.3) >AK (29) >ETP (13.4) > IMI (9.6),MER (8.5), andTIG (1.7).
Multi- Drug R (MDR) (R ≥ 3 classes) was 38.5%. MBL was found
among 2.2% (522 isolates tested) and AmpC 9.7% (235) isolates.
Co-carriage rate of ESBL and AmpC was 62.5%.CTX-M genotype
occurred in 77% (666 isolates tested). NDM-1 increased from 1.7%
in year 2008 to 5.9% in 2009. IMP,VIM MBL were absent. Overall
142 patients died (16.3%).
Conclusion: Among Enterobacteraceae causing bacteremia
MDR rates are high. CA ESBLs are high and expanding clonally at
multiple centers. As these R are plasmid mediated, measures to
limit further escalation into the community and into hospitals are
needed. CARB and TIG remain effective in the surveyed years, but
the three-fold increase in NDM between the two years is worrying
suggesting a more prudent use of CARB.
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